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The enantioselective synthesis of advanced tetracyclic 
precursors of madangamine D, bearing rings ABCD of this 
alkaloid, is reported. The saturated 14-membered ring is 
assembled from functionalized diazatricyclic intermediates 
following either ring-closing metathesis or 10 
macrolactamization strategies. 
Madangamines are a small group of marine alkaloids isolated1 
from sponges of the order Haplosclerida, biogenetically derived 
from oligomeric macrocycles bearing a partially reduced 3-
alkylpyridine moiety. Some of them possess significant in vitro 15 
cytotoxicity,2 although the low availability of samples has 
precluded further pharmacological studies. Their unique structure 
embodies a diazatricyclic core (ABC rings) unprecedented among 
natural products and two peripheral macrocyclic rings (Figure 1). 
No total syntheses of madangamines have been reported to date, 20 
so the absolute configuration of these alkaloids remains 
unknown. 
 
Fig. 1 Madangamine alkaloids. 
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 We report herein the first enantioselective synthesis of 
advanced tetracyclic precursors of madangamine D, bearing rings 
ABCD of this alkaloid.3 Starting from a phenylglycinol-derived 
oxazolopiperidone lactam,4 our approach involves the 
enantioselective construction of the bridged diazatricyclic ABC 30 
ring system common to all madangamines, appropriately 
substituted and functionalized to allow the subsequent building of 
the macrocyclic D and E rings of these alkaloids (Scheme 1). In 
our strategy, the cis-fused carbocyclic C ring was installed in 
early stages of the synthesis by stereoselective conjugate addition 35 
of an allyl residue, followed by a ring-closing metathesis 
reaction. Then, after stereoselective alkylation of the β-dicarbonyl 
moiety and reductive removal of the auxiliary oxazolidine ring, 
with simultaneous reduction of the lactam and ester groups, the 
piperidine A ring was built up taking advantage of the alcohol 40 
and alkene functionalities in the resulting cis-
octahydroisoquinoline derivative. Interestingly, the alkylation 
step allows a variety of functionalized chains to be 
stereoselectively incorporated on the quaternary C-9 stereocenter, 
thus providing potential access to a variety of madangamines. 45 
The methoxycarbonyl group in the starting lactam 1 plays a triple 
role: it acts as an activating electron-withdrawing group in the 
conjugate addition reaction as well as in the subsequent 
alkylation, and is the precursor of the aminomethyl chain required 
for the closure of the piperidine A ring. 50 
 
 
Scheme 1 Common synthetic strategy to madangamines. 
 
 Scheme 2 outlines the synthetic sequence leading to the 55 
functionalized azatricycle 7. The cis-octahydroisoquinoline ring 
system was constructed in excellent yield from the unsaturated 
lactam 1,5 by stereoselective conjugate addition of 
allylmagnesium bromide followed by ring-closing metathesis of 
the resulting diene 2 (mixture of epimers at the C=O α position) 60 
using the second-generation Grubbs catalyst. Then, the crucial 
quaternary C-9 stereocenter of madangamines was generated with 
complete facial selectivity by alkylation of the epimeric mixture 3 
with 2-(3-bromopropyl)-1,3-dioxolane,6 using NaH as the base, to 
give a single lactam 4 in 80% yield.  65 
 The reductive opening of the oxazolidine ring was 
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accomplished by treatment of 4 with Na in liquid NH3, which 
caused the cleavage of the benzylic C–N bond. A subsequent 
treatment with LiAlH4 brought about the reduction of the 
resulting unstable alkoxy(hydroxy) lactam as well as the lactam 
and ester carbonyl groups to give an amino alcohol, which was 5 




Scheme 2 Enantioselective construction of the azatricyclic ABC core of 10 
madangamines. Reagents and conditions: (a) CH2=CHCH2MgBr, CuI, 
LiCl, TMSCl, THF, –78 ºC, 20 h, 81%; (b) Grubbs 2nd gen., CH2Cl2, rt, 
18 h, 85%; (c) NaH, (CH2O)2CH(CH2)3Br, TBAI, DMF, rt, 18 h, 80%; (d) 
Na/liq. NH3, –33 ºC, 2 min; then LiAlH4, dioxane, reflux, 20 h; then 
(Boc)2O, CH2Cl2, rt, 4 h, 42%; (e) Et3N, MsCl, CH2Cl2, rt, 4 h, 97%; then 15 
NaN3, DMF, 90 ºC, 48 h, 70%; (f) m-CPBA, CH2Cl2, rt, 5 h; (g) Me3P, 
THF, 1 h; then H2O, rt, 20 h; (h) p-TsCl, Et3N, CH2Cl2, 0 ºC, 2.5 h, 40% 
(steps f-h). 
 
 After conversion of the hydroxy group into an azide via a 20 
mesylate and stereoselective m-CPBA epoxidation of the 
cyclohexene double bond, the closure of the piperidine A ring 
was performed by Me3P reduction of the intermediate azido 
epoxide 6. The initially formed amino epoxide underwent a 
smooth in situ cyclization to give a tricyclic amino alcohol, which 25 
was immediately converted to the orthogonally protected diamino 
derivative 7. The above eleven-step synthetic sequence represents 
a notable improvement, in terms of simplicity, on the sixteen-step 
route previously developed7 for the preparation of related 
diazatricyclic intermediates, for instance 8 (see Scheme 4). 30 
Notably, the method used for the removal of the phenylethanol 
moiety avoids redundant N-protection/deprotection steps and 
unnecessary functional group manipulations, which lengthened 
our previous reported synthesis. 
 Compound 7, bearing a functionalized five-carbon chain at C-35 
9, was envisaged as a suitable platform to construct the 14-
membered ring of madangamine D by ring-closing metathesis8 of 
an appropriate diene. Once the hydroxy group of 7 was protected 
by benzylation, orthogonal deprotection of the piperidine B ring 
by treatment with TFA under anhydrous conditions, followed by 40 
acylation with 7-octenoyl chloride, furnished the tricyclic amide 
9, which was then converted to the diene 10 by deprotection of 
the acetal function followed by Wittig methylenation (Scheme 3). 
As expected, diene 10 satisfactorily underwent a ring-closing 
metathesis reaction on treatment with the second-generation 45 
Grubbs catalyst under high-dilution conditions.9 Treatment of the 
resulting Z/E mixture of alkenes with H2 and PtO2 brought about 
both the reduction of the carbon-carbon double bond and the 
hydrogenolysis of the benzyloxy group, leading to tetracyclic 




Scheme 3 Assembly of the 14-membered ring of madanamine D. The 
RCM strategy. Reagents and conditions: (a) NaH, BnBr, TBAI, DMF, 55 
0.05 M, rt, 20 h, 80%; (b) TFA, CH2Cl2, rt, 30 min; then 
ClCO(CH2)5CH=CH2, Et3N, CH2Cl2, 0 ºC, 3h; then rt, 18 h, 57%; (c) 
TFA, CH2Cl2/H2O, rt, 2 h; then KOt-Bu, Ph3PCH3Br, THF, rt, 20 h, 80%; 
(d) Grubbs 2nd gen., CH2Cl2, 0.2 mM, syringe pump, reflux, 12 h, 54%; 
(e) H2, PtO2, MeOH, rt, 2 h, 78%. 60 
 
 An alternative strategy for the assembly of the 14-membered 
ring of madangamine D is outlined in Scheme 4. Starting from 
diazatricyclic alcohol 8,7 already incorporating the required 
functionalized 11-carbon chain at C-9, conventional functional 65 
group interconversions led to acetal 12, and then to carboxylic 
acid 13. After removal of the protecting Boc substituent, 
macrolactamization of the crude amino acid under high-dilution 




Scheme 4 Assembly of the 14-membered ring of madangamine D. The 
macrolactamization strategy. Reagents and conditions:(a) DMP, CH2Cl2, 
rt, 4h, 1:1 saturated aqueous NaHCO3-Na2S2O3, rt, 1 h, 78%; (b) 75 
TMSOTf, (CH2OTMS)2, CH2Cl2, 0 ºC, 30 min; then reflux, 1 h, 57%; (c) 
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H2, Pd/C, MeOH, rt, 96 h, 73%; (d) PDC, DMF, rt, 20 h, 63%; (e) TFA, 
CH2Cl2, rt, 30 min; then HOBt, EDCI, (9:1) DMF/CH2Cl2, 0.5 mM, 0 ºC, 
20 h, 43%. 
 
 In summary, from diazatricyclic intermediates 7 and 8 we have 5 
developed two different strategies for the construction of the 
saturated 14-membered ring of madangamine D, resulting in the 
first enantioselective synthesis of advanced tetracyclic precursors 
of this alkaloid. 
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